← Back to Home

DMCA Policy

DMCA Policy

Novo Nordisk Drug News is committed to complying with the Digital Millennium Copyright Act (DMCA) and U.S. copyright law. This policy outlines the procedures for submitting copyright infringement notifications and counter-notifications regarding content published on our website. We respect the intellectual property rights of others and expect our users to do the same. We will respond promptly to valid notices of alleged copyright infringement that are reported to us in accordance with the DMCA.

Filing a Notice of Copyright Infringement

If you are a copyright owner or an agent thereof and believe that any content on Novo Nordisk Drug News infringes upon your copyrights, you may submit a DMCA notice by providing our Designated Copyright Agent with the following information:

  1. A physical or electronic signature of the copyright owner or a person authorized to act on their behalf.
  2. Identification of the copyrighted work claimed to have been infringed, or, if multiple copyrighted works at a single online site are covered by a single notification, a representative list of such works.
  3. Identification of the material that is claimed to be infringing or to be the subject of infringing activity and that is to be removed or access to which is to be disabled, and information reasonably sufficient to permit Novo Nordisk Drug News to locate the material (e.g., a specific URL or detailed description).
  4. Information reasonably sufficient to permit us to contact you, such as your address, telephone number, and, if available, an email address.
  5. A statement that you have a good faith belief that use of the material in the manner complained of is not authorized by the copyright owner, its agent, or the law.
  6. A statement that the information in the notification is accurate, and under penalty of perjury, that you are authorized to act on behalf of the owner of an exclusive right that is allegedly infringed.

Please send your DMCA infringement notice clearly labeled as "DMCA Copyright Infringement Notice" via our Contact Us page.

Filing a Counter-Notification

If you believe that material you posted on Novo Nordisk Drug News was removed or disabled by mistake or misidentification, you have the right to submit a counter-notification. Your counter-notification must include the following:

  • Your physical or electronic signature.
  • Identification of the material that has been removed or to which access has been disabled and the location at which the material appeared before it was removed or access to it was disabled.
  • A statement under penalty of perjury that you have a good faith belief that the material was removed or disabled as a result of mistake or misidentification of the material to be removed or disabled.
  • Your name, address, and telephone number, and a statement that you consent to the jurisdiction of the Federal District Court for the judicial district in which your address is located, or if your address is outside of the United States, for any judicial district in which Novo Nordisk Drug News may be found, and that you will accept service of process from the person who provided the original DMCA notification or an agent of such person.

Please send your DMCA counter-notification clearly labeled as "DMCA Counter-Notification" via our Contact Us page.

For any other inquiries, please visit our Contact Us page.